No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
HK Stock MarketDetailed Quotes
02877 SHINEWAY PHARM
- 9.320
- -0.010-0.11%
Trading Apr 25 14:23 CST
7.71BMarket Cap7.20P/E (TTM)
9.540High9.280Low435.00KVolume9.540Open9.330Pre Close4.08MTurnover0.05%Turnover Ratio7.20P/E (Static)827.00MShares10.72052wk High0.99P/B7.71BFloat Cap6.55052wk Low0.47Dividend TTM827.00MShs Float23.719Historical High0.471Dividend LFY2.79%Amplitude-5.178Historical Low9.390Avg Price1000Lot Size5.05%Div YieldTTM5.05%Div Yield LFY
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Is Now The Time To Put China Shineway Pharmaceutical Group (HKG:2877) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the
SHINEWAY PHARM To Go Ex-Dividend On April 29th, 2024 With 0.461 HKD Dividend Per Share
March 30th - $SHINEWAY PHARM(02877.HK)$ is trading ex-dividend on April 29th, 2024. Shareholders of record on April 30th, 2024 will receive 0.461 HKD dividend per share on May 17th, 2024. The ex-d
China Shineway Pharmaceutical Group Grows 2023 Profit, Declares Interim 2024 Dividend
China Shineway Pharmaceutical Group (HKG:2877) posted a 2023 profit of 969.5 million yuan, or 1.28 yuan per share, up from 722.8 million yuan, or 0.96 yuan per share, a year earlier. The pharmaceutica
Shenwei Pharmaceutical (02877.HK)'s profit of RMB 969.5 million increased 34.1% year-on-year in 2023
Gelonghui, March 28, 丨 Shenwei Pharmaceutical (02877.HK) announced that for the year ended December 31, 2023, turnover was RMB 4,516 million, up 14.3% from last year; annual profit was RMB 969.5 million, up 34.1% from last year; earnings per share was RMB 128 points; declared the first interim dividend in 2024 of RMB 43 points per share; net assets of RMB 8.51 per share (equivalent to HK$9.36); and net cash per share of RMB 6.76 (equivalent to HK$7.43). In 2023, with the normalization of centralized procurement and
Shenwei Pharmaceutical (02877) will pay an interim dividend of HK$0.461 per share on May 17
Shenwei Pharmaceutical (02877) announced that it intends to pay an interim dividend of HK$0.461 per share on May 17, 2024...
SHINEWAY PHARM: 2023 ANNUAL RESULTS ANNOUNCEMENT AND DECLARATION OF 2024 FIRST INTERIM DIVIDEND
Comments
Investors are risking future disappointment by paying high for a stock with limited growth expectations. The company's poor earnings outlook isn't affecting its P/E as much as anticipated, suggesting current prices may be unreasonable.
China Shineway Pharmaceutical Group Limited's (HKG:2877) 30% Share Price Surge Not Quite Adding Up 1
China Shineway Pharmaceutical Group's low P/E ratio may be due to market expectations of limited future growth. Investors accept the low P/E, conceding future earnings probably won't provide any pleasant surprises.
The raw rate of earnings growth and significant insider holdings indicate a bright future for China Shineway Pharmaceutical Group. These factors make it a company worth keeping on the watchlist for potential investors.
1
By looking into Hong Kong Pharma stocks, I have stumbled on $SHINEWAY PHARM(02877.HK$http://www.aastocks.com/en/stocks/quote/quick-quote.aspx?symbol=02877 and these are the reasons I have bought it:
- the company has no debt
- the current price of a stock is 7.75HKD, while the company had 6.0HKD in cash according to the last financial report: http://api.aconnect.com.hk/Attachment/68080 . As the ex-dividend date passed, the company should have at least 71% of its market cap in cash. Unbelievable.
- in that financial report, the company had a very good first half of 2021.
- over the past 5 years, the company has increased cash values per year and is profitable, even with the current price it trades approximately at its book value, while at this time PE TTM is 13.047.
- the company raised its dividend and made a statement that it plans of increasing the dividends in the future, and the current yield TTM is 9.4%.
Sounds pretty good TBH $Hang Seng Index(800000.HK$
- the company has no debt
- the current price of a stock is 7.75HKD, while the company had 6.0HKD in cash according to the last financial report: http://api.aconnect.com.hk/Attachment/68080 . As the ex-dividend date passed, the company should have at least 71% of its market cap in cash. Unbelievable.
- in that financial report, the company had a very good first half of 2021.
- over the past 5 years, the company has increased cash values per year and is profitable, even with the current price it trades approximately at its book value, while at this time PE TTM is 13.047.
- the company raised its dividend and made a statement that it plans of increasing the dividends in the future, and the current yield TTM is 9.4%.
Sounds pretty good TBH $Hang Seng Index(800000.HK$
2
$SHINEWAY PHARM(02877.HK$ wow, highest 8.25 and close 7.57, what happened??
Read more
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg